Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.

× No keyword cloud information.

46 in total

1. Understanding the natural history of chronic HBV and HCV infections.

Authors: David L Thomas; Adrian M Di Bisceglie; Harvey J Alter; Norah A Terrault
Journal: J Fam Pract Date: 2010-04 Impact factor: 0.493

Review 2. [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors: D Meyer-Olson; K Hoeper; R E Schmidt
Journal: Z Rheumatol Date: 2010-12 Impact factor: 1.372

3. Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B.

Authors: Yoshitaka Ueno; Shinji Tanaka; Masaru Shimamoto; Yoshihiro Miyanaka; Toru Hiyama; Masanori Ito; Yasuhiko Kitadai; Masaharu Yoshihara; Masaharu Sumii; Kazuaki Chayama
Journal: Dig Dis Sci Date: 2005-01 Impact factor: 3.199

Review 4. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

Authors: L H Calabrese; N N Zein; D Vassilopoulos
Journal: Ann Rheum Dis Date: 2006-04-20 Impact factor: 19.103

5. Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening?

Authors: Gunda Millonig; Michaela Kern; Othmar Ludwiczek; Karin Nachbaur; Wolfgang Vogel
Journal: World J Gastroenterol Date: 2006-02-14 Impact factor: 5.742

Review 6. Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Authors: Francesca De Nard; Monica Todoerti; Vittorio Grosso; Sara Monti; Silvia Breda; Silvia Rossi; Carlomaurizio Montecucco; Roberto Caporali
Journal: World J Hepatol Date: 2015-03-27

7. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.

Authors: Eva C Schwaneck; Manuel Krone; Sonja Kreissl-Kemmer; Benedikt Weißbrich; Johannes Weiss; Hans-Peter Tony; Ottar Gadeholt; Marc Schmalzing; Andreas Geier
Journal: Clin Rheumatol Date: 2018-09-20 Impact factor: 2.980

Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate.